Alachua Government Services, Inc. clinical trials
Acquired by National Resilience, Inc., 2021 · source ↗
The registry lists 4 studies whose lead sponsor is Alachua Government Services, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 23, 2026.
- 4studies on the registry
- 0open to participants now
Before and after it joined National Resilience, Inc.
- First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.
- 3
- First submitted after Alachua Government Services, Inc. became part of National Resilience, Inc.
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 4 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed4100%
Over the years
- 208
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Alachua Government Services, Inc.4 studies
Something wrong with this grouping? Tell us on the National Resilience, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All National Resilience, Inc. studies →
- Evaluating Technologies for Point-of-Care Blood Collections by PatientsCompletedNCT06507566Not applicable
Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted after Alachua Government Services, Inc. became part of National Resilience, Inc.
- Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and OlderCompletedNCT00782431Phase 3
Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.
- Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza InfectionCompletedNCT00800605Phase 3
Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.
- Inactivated Split Virus Seasonal Influenza Vaccine (Vero Cell-Derived)CompletedNCT01773928Phase 3
Sponsor listed in the registry: Alachua Government Services, Inc. · First submitted before Alachua Government Services, Inc. became part of National Resilience, Inc.